Beginning Cash: The amount of cash reported by the company on its previous statement.
HTG Molecular Diagnostics, Inc. (HTGMQ) had Beginning Cash of $9.60M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$6.37M |
|
$-21.59M |
|
$4.57M |
|
$1.79M |
|
$27.20M |
|
$-20.83M |
|
$-0.75M |
|
$-21.58M |
|
$-21.58M |
|
-- |
|
-- |
|
$-21.59M |
|
-- |
|
$-20.83M |
|
$-19.84M |
|
0.89M |
|
0.89M |
|
$-24.28 |
|
$-24.28 |
|
| Balance Sheet Financials | |
$15.65M |
|
$0.60M |
|
$2.13M |
|
$17.78M |
|
$8.27M |
|
-- |
|
$4.12M |
|
$12.39M |
|
$5.39M |
|
$5.39M |
|
$5.39M |
|
2.21M |
|
| Cash Flow Statement Financials | |
$-18.41M |
|
$12.42M |
|
$8.60M |
|
|
Beginning Cash |
$9.60M |
$12.21M |
|
$2.61M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
-- |
|
0.71 |
|
28.18% |
|
-327.19% |
|
-327.19% |
|
-311.66% |
|
-339.03% |
|
-339.20% |
|
$-18.33M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
5.03 |
|
4.48 |
|
81.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
$2.44 |
|
$-20.62 |
|
$-20.71 |
|